Physician profile
Nirali Patel
NPI 1689225005
$1,004.66
in general payments reported to CMS, 2019-2025
21 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $293 · 2022: $393 · 2023: $64.33 · 2024: $69.81 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $185.00 | 2025 | Restrata Wound Matrix |
| Glaxosmithkline, LLC. | $102.09 | 2021-2023 | Shingrix, Trelegy Ellipta |
| Novo Nordisk INC | $93.98 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.52 | 2021-2023 | Jardiance |
| Abbvie INC. | $66.98 | 2021-2022 | |
| Amgen INC. | $52.79 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $47.97 | 2021-2022 | |
| Inari Medical, INC. | $43.22 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $42.42 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.22 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $39.95 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $35.46 | 2021 | |
| Baxter Healthcare | $26.59 | 2024 | |
| Biogen, INC. | $23.92 | 2021 | |
| Ibsa Pharma INC. | $23.19 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $18.92 | 2022 | |
| Arbor Pharmaceuticals, INC. | $15.60 | 2021 | |
| Lilly USA, LLC | $15.56 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $14.80 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $13.35 | 2022 | |
| Esperion Therapeutics, INC. | $13.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirali Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.